Herman Bril

Hoofddorp, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer.

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer.

Journal: BMC cancer

Published: June 21, 2021

Microbiota composition and mucosal immunity in patients with asymptomatic diverticulosis and controls.

Microbiota composition and mucosal immunity in patients with asymptomatic diverticulosis and controls.

Journal: PloS one

Published: March 18, 2021

Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.

Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 12, 2020

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study.

Journal: BMC gastroenterology

Published: May 22, 2019

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer.

Journal: Oncotarget

Published: May 10, 2017

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.

Journal: British journal of cancer

Published: June 29, 2016

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients.

Journal: Oncotarget

Published: April 06, 2016

Intraneural perineurioma of the digital nerve: a case report.

Intraneural perineurioma of the digital nerve: a case report.

Journal: The Journal of hand surgery, European volume

Published: June 28, 2015

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

Journal: Oncotarget

Published: May 06, 2015

Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.

Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.

Journal: International journal of cancer

Published: February 27, 2015

The curious case of the orange coloured tonsils.

The curious case of the orange coloured tonsils.

Journal: International journal of pediatric otorhinolaryngology

Published: May 23, 2014

Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.

Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients.

Journal: Molecular oncology

Published: September 16, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026